Seikagaku Corporation
Research Seikagaku Corporation (4548.T) on Bullrun: market cap JPY 31.61B, P/E 19.0, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4548.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyJPY
- Market capJPY 31.61B
- P/E19.0
- Dividend yield4.4%
- Financial periodFY2026
- RevenueJPY 36.65B
- Revenue growth-6.9%
- Net incomeJPY 1.47B
- Free cash flow-JPY 7.37B
- Gross margin43.6%
Valuation Snapshot
latest market cap is JPY 31.61B; P/E is 19.0; dividend yield is 4.4%.
Peer valuation comparison
Latest P/E is 19.01x versus a Healthcare sector median of 21.69x (12.3% below).
Latest dividend yield is 4.41% versus a Healthcare sector median of 2.41% (83.0% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 36.65B | JPY 1.47B | -JPY 7.37B | 43.6% | 26.99 | JPY 8.94B | JPY 356.00M | JPY 75.30B |
| FY2025 | JPY 39.37B | JPY 1.21B | -JPY 179.00M | 48.6% | 22.25 | JPY 15.13B | JPY 380.00M | JPY 73.19B |
| FY2024 | JPY 36.21B | JPY 2.19B | -JPY 4.05B | 46.6% | 40.08 | JPY 15.44B | JPY 396.00M | JPY 72.28B |
| FY2023 | JPY 33.46B | JPY 2.24B | -JPY 478.00M | 53.9% | 40.49 | JPY 23.45B | JPY 389.00M | JPY 67.22B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 31.61B | 19.0 | 3.5% | 20 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 20 JPY, yield 4.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 25 JPY |
| FY2025 | 30 JPY |
| FY2024 | 28 JPY |
| FY2023 | 26 JPY |
| FY2022 | 28 JPY |
About Seikagaku Corporation
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the ARTZ, ARTZ Dispo, VISCO-3, JOYCLU, Gel-One, Hylink, and SUPARTZ brands; ophthalmic surgical aids under the OPEGAN and SHELLGAN brand names;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Seikagaku Corporation's market cap?
Seikagaku Corporation's market capitalization is JPY 31.61B.
What is Seikagaku Corporation's P/E ratio?
Seikagaku Corporation's price-to-earnings (P/E) ratio is 19.0.
Does Seikagaku Corporation pay a dividend?
Seikagaku Corporation has a dividend yield of 4.4%.
What does Seikagaku Corporation do?
Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business.